The Regents of the University of California

États‑Unis d’Amérique

Nouveaux brevets et marques déposées la semaine dernière

Dernière mise à jour : 2026-04-11

Sommaire

Brevets

Marques
8 0
5 0
7 0
0


Commandez votre montre hebdomadaire The Regents of the University of California

Viewing 1 - 20 of 20


marques


brevets

# ID Juridiction Title
1 19349737 Bioelectronic Localized Antimicrobial Stimulation Therapy (BLAST) through selective excitability
2 19410663 Methods and Compositions for Treatment of Angiogenic Disorders Using Anti-VEGF Agents
3 19113381 COVALENT, CHEMOGENETIC ACTIVATORS FOR K2P POTASSIUM CHANNELS AND USES THEREOF
4 US2025049548 COMPOSITIONS AND METHODS FOR TREATING PAIN DISORDERS
5 19325211 Nitrosation Reagents and Methods
6 19353883 HEALTH CONDITION TREATMENT VIA ADAPTIVE LOOP STIMULATION PATCH
7 18993400 GENE EXPRESSION-BASED IDENTIFICATION OF EARLY LYME DISEASE
8 19112948 SODIUM-DEFICIENT CHLORIDE-BASED SODIUM SOLID ELECTROLYTE
9 19156782 Systems and Methods for Automated Diagnosis of Disease Related Risk Factors in 3D Biomedical Imaging
10 US2025049510 COMPOSITIONS AND METHODS FOR MODULATING NEURAL ACTIVITY
11 US2025049086 MULTI-MATERIAL DIGITAL LIGHT PROCESSING PRINTING SYSTEM AND METHOD USING CENTRIFUGAL AND ULTRASONIC-ASSISTED WASHING
12 US2025047669 SKIN MICROBIOME-BASED METHODS FOR ACNE ASSESSMENT AND TREATMENT
13 US2025048780 METHODS OF MODULATING CIRCULAR RNA TRANSLATION BY RNA-BINDING PROTEINS
14 US2025049213 METHODS FOR TREATING AUTOIMMUNE CONDITIONS
15 US2025049188 METHOD AND SYSTEM WITH REAL-TIME STIMULATION ARTIFACT REMOVAL FOR CLOSED-LOOP NEUROMODULATIONS
16 03215864 BISPECIFIC BINDING AGENT-LIGAND FUSIONS FOR THE DEGRADATION OF TARGET PROTEINS
17 03215311 GENETIC MODIFICATION OF MAMMALIAN CELLS TO CONFER RESISTANCE TO CSF1R ANTAGONISTS
18 03305935 COMPOSITIONS AND METHODS FOR TREATING PAIN DISORDERS
19 03213286 NANOPOROUS LITHIUM VANADIUM FLUOROPHOSPHATE MATERIALS AND CATHODES FOR FAST CHARGING LI-ION BATTERIES
20 03216825 PROMOTERS FOR VIRAL-BASED GENE THERAPY